Description
5th 5th Lyophilisation Conference 2011 Optimising technologies & techniques for stability, delivery and longevity of pharmaceuticals and biologics
Lyophilisation is one of the fastest growing markets, with estimated revenue of $1.77bn (for products and services) in 2009, total revenues in this market is expected to reach $3.25bn in 2015 and $6.15bn by 2025. This growth will be driven primarily by the introduction of new products, specifically biologics such as monoclonal antibodies (mAbs) and recombinant proteins.
